Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is rising globally. However, clinically effective antiviral treatments are not established. Favipiravir may prevent pneumonia and acute respiratory distress syndrome aggravation. We describe SARS-CoV-2-positive patients, two o...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hidenori, Iwasaki, Yoshinobu, Watanabe, Takayasu, Ichinose, Naoki, Okada, Yasusei, Oiwa, Akito, Kobayashi, Takehiro, Moriya, Mariko, Oda, Toshimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441042/
https://www.ncbi.nlm.nih.gov/pubmed/32829044
http://dx.doi.org/10.1016/j.ijid.2020.08.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441042/
https://www.ncbi.nlm.nih.gov/pubmed/32829044
http://dx.doi.org/10.1016/j.ijid.2020.08.047

Ejemplares similares